From: Mucinous tubular and spindle cell renal cell carcinoma: a review of clinicopathologic aspects
Authors (yr) | No. cases | AMACR | AE1/AE3 | CK7 | CK19 | EMA | Vimentin | RCC maker | CD10 | CD15 | HMWCK | E-cadherin |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Parwani et al. (2001) [3] | 4 | NA | 4/4 | 4/4 | 0/4 | 4/4 | 4/4 | NA | NA | 0/4 | 4/4 | NA |
Rakozy et al. (2002) [4] | 5 | NA | 5/5 | NA | 4/5 | 5/5 | 2/5 | 0/5 | NA | NA | NA | NA |
Hes et al. (2002) [5] | 11 | NA | 11/11 | 9/9 | NA | 11/11 | 11/11 | NA | NA | 0/11 | NA | NA |
Ferlicot et al. (2005) [14] | 15 | 12/12 | 13/13 | 14/14 | 13/13 | 14/14 | 2/14 | 5/11 | 3/14 | 4/14 | 3/14 | 10/11 |
Paner et al. (2006) [15] | 27 | 25/27 | NA | 22/27 | NA | 19/20 | NA | 2/27 | 4/27 | NA | 4/26 | NA |
Fine et al. (2006) [13] | 17 | 9/13 | NA | 12/13 | NA | NA | NA | NP | NA | NA | NA | NA |
Shen et al. (2007) [16] | 12 | 11/12 | NA | 11/12 | NA | NA | NA | 11/12 | 6/12 | 11/12 | NA | NA |
Wu et al. (2014) [6] | 8 | 7/8 | NA | 5/8 | NA | 3/8 | 6/8 | NA | NA | NA | NA | NA |